Authors
Loading...
Review outlines challenges in preclinical assessment of car-t cells in hematologic cancers, suggesting potential improvements.
Tomai et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: